UPC Analytics
DEEN
Übersicht · Eingereicht:

CC_49716/2024

NOVEL ANTITUMORAL USE OF CABAZITAXEL

Verletzungs-Hauptverfahren:UPC_CFI_145/2024

NichtigkeitWiderklage auf NichtigkeitMunich LDCounterclaim for revocation
  • 2025-01-24Nur prozessualproceduralCounterclaim for revocation

    The Munich Local Division issued a procedural order in the infringement actions by Sanofi (and successor entities) against multiple generic pharmaceutical companies (Accord, STADA, Dr Reddy's, Zentiva) concerning EP 2 493 466 (UPC_CFI_145/2024 and related cases). The order concerns case management — identifying parties and representatives across the eight consolidated cases relating to counterclaims for revocation.